- Genprex ( NASDAQ: GNPX ) entered into a securities purchase agreement with a single, healthcare-focused institutional investor for the purchase and sale of 3.81M shares along with its warrants at a combined purchase price of $1.05/share in a registered direct offering.
- Warrants, exercisable immediately, will have an exercise price of $1.10 and will expire five years from issuance date.
- Gross proceeds are expected to be ~$4M; net proceeds to be used for general working capital purposes.
- Offer closing is expected to occur on or about Mar.1, 2023.
- Shares trading 20.6% down premarket.
For further details see:
Genprex to raise $4M in stock offering to a single, healthcare-focused institutional investor